Synlait files application for leave to appeal
Synlait Milk Ltd · 1028 Heslerton Road, RD13 Rakaia, Canterbury, New Zealand · +643 373 3000 · www.synlait.com
SYNLAIT MILK LIMITED ANNOUNCEMENT NZX: SML
ASX: SM1
7 JUNE 2019
SYNLAIT FILES APPLICATION
FOR LEAVE TO APPEAL TO
THE SUPREME COURT
Synlait (NZX: SML; ASX: SM1) has filed an application for leave to appeal to the Supreme Court in relation
to the removal of land covenants on its Pokeno land.
The application to the Supreme Court was filed in Wellington today.
In February 2018 Synlait announced the conditional purchase of 28 hectares of land in Pokeno to establish
its second nutritional powder manufacturing site.
In November 2018 the High Court removed covenants over the land which would hinder Synlait’s
development of the land. Synlait then took ownership of the land.
In May 2019 the Court of Appeal overturned the High Court decision to remove historic covenants.
“This is really just the next step in the process as we continue to progress all our options,” says Synlait’s
CEO, Leon Clement.
“We are also still in continued conversations with all parties and we remain confident of a positive
outcome,” he says.
Synlait’s has reiterated that the plans for the Pokeno site haven’t changed.
“We will continue to work towards the existing project timetable including the build, commissioning and
production,” says Mr Clement.
“We remain committed to Pokeno as well as our shareholders and other stakeholders in Pokeno such as
our farmers, suppliers and staff,” he says.
ENDS
For more information about Synlait visit www.synlait.com
or contact:
Jessica Thorn
Senior Communications Advisor, Synlait Milk
Synlait Milk Ltd · 1028 Heslerton Road, RD13 Rakaia, Canterbury, New Zealand · +643 373 3000 · www.synlait.com
P: +64 3 373 3353
E: Jessica.thorn@synlait.com
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.